Canopy Biosciences
Latest round
- Series A
Last raised
- May 2018
Total raised
- $2.4M
Investors
- 6
About Canopy Biosciences
Canopy Biosciences LLC, founded in 2016, is based in St. Louis, US. The company focuses on spatial biology solutions, and was acquired by Bruker Corporation in September 2020. The founder, Crystal Winkeler, has a history of leadership in biotechnology innovations.Canopy Biosciences LLC provides state-of-the-art spatial molecular solutions, including the CosMx® Spatial Molecular Imager for high-plex single-cell spatial transcriptomics, CellScape™ for spatial proteomics, and GeoMx® Digital Spatial Profiler for whole-tissue spatial multiomics analysis.The company generates revenue through direct sales and partnerships, adopting a B2B model.Canopy Biosciences LLC aims to expand its offerings by developing new products in spatial biology with plans for launches in the next year. The company is targeting expansion into Europe and Asia-Pacific markets by 2025 to broaden its global reach.
Who invested in Canopy Biosciences
6 investors across 1 round
See all investors in Canopy Biosciences
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series A
May 22, 2018
Amount
$2.4M
Investors
Questions about Canopy Biosciences
Who invested in Canopy Biosciences?
Canopy Biosciences has 6 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Canopy Biosciences raised?
Canopy Biosciences has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Canopy Biosciences last raise money?
Canopy Biosciences's most recent round on record is a Series A, in May 2018.
What does Canopy Biosciences do?
Canopy Biosciences LLC, founded in 2016, is based in St.
Where is Canopy Biosciences headquartered?
Canopy Biosciences is headquartered in St. Louis, US.
Which VCs invest in companies like Canopy Biosciences?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Canopy Biosciences's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like Canopy Biosciences? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.